EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
09-11 October 2015 , Sofia, Vitosha Park Hotel
Congrès francophone de pharmacie hospitalière
Centre des congrès de Reims
Evénement majeur de l’année pharmaceutique hospitalière, Hopipharm réunira du 19 mai au soir au 22 mai 2015 le monde de la pharmacie hospitalière et de ses partenaires industriels autour de thèmes scientifiques, techniques et professionnels.
Ainsi, plus de 1.400 participants pharmaciens hospitaliers, assistants, attachés, internes, cadres de santé, préparateurs, partenaires industriels de santé et institutionnels vont pouvoir participer à de nombreuses sessions de formation, ateliers de travail, assemblées et tables rondes.
Hopipharm est aussi un temps privilégié de rencontres et d’échanges professionnels dans l’espace qui regroupe une centaine de sociétés partenaires industriels du médicament et du dispositif médical, partenaires institutionnels, associations, éditeurs informatiques hospitaliers, sociétés de logistique et robotique hospitalière.
www.hopipharm.fr
www.synprefh.org
Informations : hopiharm.reims@outlook.fr
The Cancer & the Kidney International Network (C-KIN) will hold its first annual conference on 14-15 April 2015 at the Crowne Plaza Brussels – Le Palace in Brussels, Belgium. Founded in March 2014, C-KIN is the first international network of healthcare professionals, clinicians, and researchers focusing on kidney-related issues in patients with cancer. The C-KIN Annual Conference aims to improve integrated patient care by gathering professionals for networking opportunities and to exchange developments in research and education in the field of onconephrology. Featured topics include evaluation of renal function in cancer patients and renovascular safety of antiangiogenics. Abstract submission for poster presentations is open until 8 March 2015. The deadline for online registration discount is 9 March 2015. For more information on C-KIN and its upcoming conference, please visit www.c kin.org/about-c-kin/ and www.c-kin.org/conference2015
How do We Improve Health without Betraying Confidentiality within Current and Upcoming EU Regulations?
In the 2015 Annual Conference we will debate the tensions between confidentiality and transparency in health research. It will provide an opportunity to hear up to date information from experts involved, listen to differing viewpoints, particularly those of patients and patient groups whose voice must be central in this debate. It will also present opportunity to consider current solutions.
Tangible outcomes will be
1. Description and report on data protection arrangements in research across the EU through the EFGCP Research Ethics Committee survey
2. Debate on and development of a draft statement on secondary use of data in research
3. EFGCP report and recommendations that will be provided to those involved in the legislative process.
Progress in our understanding of the factors underpinning good health is leading us towards developing better treatments. Much of this advance is founded on the use of personal data, such as our health records. Without access to this data, medical progress would be seriously impeded and proposed restrictive access to clinical information poses a serious, immediate threat to research. There is a real danger we will sleepwalk into a position where we undermine health research designed to provide health care benefit.
This has been recognised within the discussions around the new EU Clinical Trial Regulations but it could be irreparably damaged by proposed Data Protection Regulations. While protection of privacy must be a central tenet of any legislation, some amendments will make vital research unworkable. The use of personal health data in research would become impossible in practice. This poses a significant risk to our health. Our conference will seek to strike a balance in answering the key questions.
Multi-Stakeholder Workshop of the Joint EFGCP-MedTech Europe Medical Technology Working Party on ‘Mitigating Risks in the Lifecycle of Medical Devices: Options and Challenges in Building Clinical Evidence’ – The Hotel, Brussels, Belgium
The upcoming European Regulation on Medical Devices will change the landscape for the development of medical devices. This multi-stakeholder workshop of the new joint EFGCP-MedTech Europe Working Party will offer the floor for an exchange of views and opinions on topics of particular complexity and concern in the new Regulation with a view to providing input to the relevant decision-makers.
Setting effective ethical and quality clinical standards for medical technology studies is critical to ensuring that patients have access to safe and effective treatment. For the first time, patient representatives, healthcare providers, ethicists, competent authorities, industry and policymakers will be able to present and discuss their needs and expectations, the options and opportunities for mitigating risks in the development and full life cycle of medical devices and the best ways of building clinical evidence.
Objectives:
• Understand the differences between clinical trials with medicines and medical devices
• Identify suitability of concepts and lessons learned in medicines development for clinical development of medical devices
• Discuss how best to ensure the required ethical and quality standards in medical device trials
We are very pleased to announce that in 2014, the International Pharmaceutical Federation (FIP) will host its Annual Congress in Bangkok, in collaboration with the Pharmaceutical Association of Thailand under Royal Patronage (PAT) and its Thai partners.
Access to medicines, care and information – The pharmacist is at the heart of it all. The 2014 FIP Congress in Bangkok, Thailand, invites pharmacists and pharmaceutical scientists from all over the world to delve into the globally pressing issue of access to medicines – and healthcare in general – and to work towards increasing the role of the pharmacist in the provision of healthcare services.
Examining key challenges such as medicines availability, health workforce distribution and managing the vast amounts of variable information accessible to patients, the FIP Congress in Bangkok will offer all participants the opportunity to increase their impact in ensuring access to health by providing medicines, care and information.
All Thai pharmacists are greatly looking forward to welcoming the participants of the 2014 FIP Congress in Bangkok to learn more about pharmacy in Thailand and to experience the wonderful Thai hospitality!
Come to the FIP Congress in Bangkok and gather at the most important meeting place for our global network of pharmacists. We look forward to seeing you there!
Venue: Copenhagen, Denmark
More information here.
Find out how GS1 can enable patient safety and improve efficiency in the hospital setting and how GS1 Standards are implemented in the care giving environment.
"The missing link in patient safety" webinar is presented by Thomas De Rijdt, UZ Leuven, Belgium.
Date: Thursday 8 May
Time: 8:30-9:30 (U.S. East Coast)
13:30-14:30 (GMT)
14:30-15:30 (Europe CET)
REGISTER FOR THE FREE WEBINAR HERE
Venue: Melbourne, Australia
www.worldcardiocongress.org
.png)
Theme: "Personalized Medicine: the future of pharmacy"
Venue: Valencia, Spain
This event will bring together hundreds of pharmacy students and young graduates from all around Europe.
The program consists of an educational symposium, workshops, trainings, General Assembly as well as a colorful social program.
Professionals are also invited to engage in discussions with students on current pharmacy topics in order to identify the core debates and come up with possible solutions for the future of European pharmacy.
For more information please visit: http://epsa-aa2013.com or www.epsa-online.org
